<DOC>
	<DOCNO>NCT01899131</DOCNO>
	<brief_summary>1 . To investigate hard soft tissue adaptation maintenance Laser-Lok® microchannels permanent abutment/ new Laser-Lok® implant assembly perform clinical radiographic evaluation . 2 . To investigate effect inter-implant spacing ( minimum 2 3 mm ) hard soft tissue . 3 . To perform clinical radiographic evaluation abutment/implant assembly 2 year .</brief_summary>
	<brief_title>A Prospective Clinical Radiographic Assessment New Platform-switched Laser Lok Implants</brief_title>
	<detailed_description>- Screening ( Inclusion/ Exclusion Criteria ) - Day Surgery : Dental CT scan/ periapical radiograph / clinical picture / clinical examination ( probe depth , BOP , gingival recession ) . - Implant Restoration Day : Post-restoration periapical radiograph/ clinical picture/ clinical examination ( probe depth , BOP , gingival recession ) . - 6 month , 1 Year 2 Year Post Restoration : periapical radiograph / clinical picture / clinical examination ( probe depth , BOP , gingival recession ) .</detailed_description>
	<criteria>1 . Male female , 2070 year age , request dental implant treatment option rehabilitation . 2 . Subjects willing sign inform consent , participate return followup visit . 3 . Subjects without significant medical history currently medication might complicate result . 4 . Subjects present edentulous area require toothreplacement option . 1 . Subjects meet inclusion criterion cooperate protocol schedule . 2 . Subjects receive fail previously place dental implant . 3 . Subjects require onlay ridge augmentation procedure area achieve adequate bone volume placement dental implant . 4 . Subjects significant untreated periodontal disease , caries , infection chronic inflammation oral cavity within two adjacent tooth position clinical trial area . 5 . Subjects use nicotinecontaining product within 3 week prior surgery . 6 . Subjects insulindependent diabetic Hgb1c level &gt; 6.5 % . 7 . Subjects history malignancy within past 5 year ( except basal squamous cell carcinoma skin situ cervical carcinoma ) . 8 . Subjects nurse pregnant . 9 . Subjects presently take medication ( except estrogen/progesterone therapy ) undergoing treatment know effect bone turnover . 10 . Subjects diseases affect bone metabolism ( exclude idiopathic osteoporosis ) . 11 . Subjects history autoimmune disease , document allergy multiple allergy component agent use study . 12 . Acutely infected defect site . 13 . Immediate implant site .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>dental implant</keyword>
	<keyword>crestal bone</keyword>
	<keyword>gingival margin</keyword>
</DOC>